Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1048652 | 0.87 | ALDH1A1 (0.33) | GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL18436948 | 0.87 | GABRA1 (0.31) | GABRA1GABRB2 | |
| SCHEMBL29466647 | 0.84 | TAAR1 (0.38) | GABRA1GABRB2TRPA1ALDH1A1TSHR | |
| SCHEMBL629949 | 0.84 | TAAR1 (0.38) | GABRA1GABRB2TRPA1ALDH1A1TSHR | |
| SCHEMBL4828640 | 0.82 | GABRA1 (0.35) | GABRA1GABRB2TRPA1ALDH1A1TSHR | |
| SCHEMBL1294517 | 0.82 | TAAR1 (0.43) | ALDH1A1 | |
| SCHEMBL31057408 | 0.82 | TAAR1 (0.37) | GABRA1GABRB2 | |
| SCHEMBL3871871 | 0.82 | TAAR1 (0.37) | GABRA1GABRB2 | |
| SCHEMBL3304485 | 0.82 | TAAR1 (0.38) | GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL4455672 | 0.82 | GABRA1 (0.31) | GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 881 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912794-B2 | Modulation of structured polypeptide specificity | Bicyclerd Limited (GB) | 2024-02-27 | — | — | US | claimed |
| WO-2023229390-A1 | METHOD FOR MANUFACTURING THIN-FILM COMPOSITE MEMBRANE FOR WATER TREATMENT, HAVING EXTREME ACID AND BASE STABILITY | 고려대학교 산학협력단 | 2023-11-30 | — | — | WO | claimed |
| US-11753444-B2 | Modulation of structured polypeptide specificity | Bicyclerd Limited (GB) | 2023-09-12 | — | — | US | claimed |
| US-11524989-B2 | AML antigens and uses thereof | KLING BIOTHERAPEUTICS B.V. (NL) | 2022-12-13 | — | — | US | claimed |
| EP-2474613-B2 | Methods and compositions | BICYCLERD LTD (GB) | 2022-02-16 | — | — | EP | claimed |
| US-20210207127-A1 | LIGANDS AND METHODS OF SELECTING BINDING TARGETS FOR SUCH | BICYCLERD (GB) | 2021-07-08 | — | — | US | claimed |
| US-20210122786-A1 | MODULATION OF STRUCTURED POLYPEPTIDE SPECIFICITY | Bicyclerd Limited (GB) | 2021-04-29 | — | — | US | claimed |
| EP-3803878-A2 | LIGANDS AND METHODS OF SELECTING BINDING TARGETS FOR SUCH | Bicyclerd Limited (GB) | 2021-04-14 | — | — | EP | claimed |
| CN-112534504-A | Ligands and methods of selecting binding targets for the ligands | 拜斯科阿迪有限公司 | 2021-03-19 | — | — | CN | claimed |
| US-20210079043-A1 | MODULATION OF STRUCTURED POLYPEPTIDE SPECIFICITY | Bicyclerd Limited (GB) | 2021-03-18 | — | — | US | claimed |
| EP-1844337-A1 | BINDING COMPOUNDS, IMMUNOGENIC COMPOUNDS AND PEPTIDOMIMETICS | PEPSCAN SYSTEMS B.V. (NL) | 2007-10-17 | — | — | EP | claimed |
| CN-1907929-A | Method of continuous and high-yield separating and extracting 1,3-dihydroxypropane from fermentation liquid | UNIV EAST CHINA SCIENCE & TECH (CN) | 2007-02-07 | — | — | CN | claimed |
| WO-2006078161-A1 | BINDING COMPOUNDS, IMMUNOGENIC COMPOUNDS AND PEPTIDOMIMETICS | PEPSCAN SYSTEMS B.V. (NL) | 2006-07-27 | — | — | WO | claimed |
| US-20060073518-A1 | Method for selecting a candidate drug compound | PEPSCAN SYSTEMS B. V. (NL) | 2006-04-06 | — | — | US | claimed |
| EP-1597585-A2 | METHOD FOR SELECTING A CANDIDATE DRUG COMPOUND | PEPSCAN SYSTEMS B.V. (NL) | 2005-11-23 | — | — | EP | claimed |
| WO-2004077062-A2 | METHOD FOR SELECTING A CANDIDATE DRUG COMPOUND | PEPSCAN SYSTEMS B.V. (NL) | 2004-09-10 | — | — | WO | claimed |
| EP-1452868-A2 | Method for selecting a candidate drug compound | PEPSCAN SYSTEMS B.V. (NL) | 2004-09-01 | — | — | EP | claimed |
| EP-0620500-A2 | Resist and pattern formation using the same | HITACHI, LTD. (JP) | 1994-10-19 | — | — | EP | claimed |
| US-5208133-A | Photosensitive resin composition | SONY CORPORATION (JP) | 1993-05-04 | — | — | US | claimed |
| US-5164477-A | Preparation of polyoxazolines | Kobayashi, Shiro (JP) | 1992-11-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11753444-B2 | Modulation of structured polypeptide specificity | KLKB1, KLK5, KLK1 | GABRA1 3337/4885GABRB2 3494/4885TRPA1 4207/4885 |
| US-20210079043-A1 | MODULATION OF STRUCTURED POLYPEPTIDE SPECIFICITY | KLKB1, KLK5, KLK1 | GABRA1 3337/4885GABRB2 3494/4885TRPA1 4207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.